Invicta Diagnostic Ltd. (PC Diagnostics) has received a strategic secondary investment of 1.37% stake by Acharya Manish Grover (MD, Jeena Sikho Lifecare), signaling strong confidence in its upcoming IPO.
Glimpse:
Grobiz SME Opportunity Fund’s Promoter, Acharya Manish Grover, has bought 1.27 lakh shares of Invicta Diagnostic via a secondary transaction. Invicta plans to raise around ₹28.12 crore through its upcoming IPO, which has received in-principle approval from NSE Emerge
Invicta Diagnostic Limited, operating under the brand PC Diagnostics, has secured a ~1.37% shareholding through a strategic secondary acquisition by Acharya Manish Grover, Managing Director of Jeena Sikho Lifecare. Grover acquired 1.27 lakh equity shares, demonstrating strong investor faith in Invicta’s growth trajectory and its IPO plans.
This comes at a pivotal moment: Invicta recently filed its Draft Red Herring Prospectus (DRHP) with NSE Emerge and received in-principle IPO approval. Through the IPO, the company aims to raise ₹28.12 crore via a fresh issue of 33.08 lakh shares.
The IPO proceeds will be used significantly for capital expenditure about ₹21.11 crore is earmarked for investing in advanced medical equipment and opening five new diagnostic centres in Maharashtra (Kalyan, Vasai-Virar, Malad-Kandivali, Akola and more). Invicta is emphasizing scaling its diagnostic footprint in a high-growth region with this fundraise.
Promoter Rohit Prakash Srivastava said that the backing from Grover reinforces the company’s vision of building a “future-ready, scalable diagnostics network,” especially as it prepares to go public.
“This strategic investment from a respected healthcare leader underscores our IPO mission to expand diagnostic access without compromising quality.”
By
HB Team
